This piece of software is a WordPress child theme boilerplate for Divi. It aims to secure the site, to configure it to meet the GDPR requirements and to optimize it for a better page speed. In ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure ...

Divi’s Laboratories Ltd, India’s second-largest pharmaceutical company by market capitalization, is expected to report a 14-18% jump in revenue and robust margin expansion for the quarter ended 30 ...

DIVI stands out among international dividend ETFs due to its methodology emphasizing value, earnings stability, and profitability, not just high yield. The ETF's optimization process allows for growth ...

Actress Divi Vadthya has released a firm statement through an audio clip, urging the media and social media users not to drag her name into the ongoing drug controversy linked to singer Mangli’s ...

Divi's Laboratories share price: Pharmaceutical giant Divi's Laboratories (Divi’s Labs) shares were buzzing in trade on Monday, May 26, 2025, with the scrip rising up to 4.37 per cent to hit a record ...

Divi's Labs shares price: Shares of Divi's Laboratories jumped over 4 per cent to hit an intraday high ₹5,914 after the company signed a supply agreement with a global pharma company. According to the ...

The pharmaceutical company Divi's Laboratories on Friday said that it has signed a supply agreement with a global pharmaceutical company and is planning a capacity addition of nearly Rs 700 crore, ...

Divi's Laboratories announced today that it has entered into a long-term manufacturing and supply agreement with a global pharmaceutical company. The agreement focuses on the manufacturing and supply ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Ever since I was a kid, I’ve dreamed of thicker, fuller hair. As a baby, my mom told ...

International brokerage Citi reiterated its bullishness over Divi's Laboratories by naming it as its top pick in the Indian pharma sector, driven by the drugmaker's expanding pipeline for its contrast ...